At 15.7% CAGR, the Middle East & Africa Nasal Irrigation Devices Market is projected to be worth US$ 54.84 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa nasal irrigation devices market was valued at US$ 22.91 million in 2022 and is expected to reach US$ 54.84 million by 2028, registering a CAGR of 15.7% from 2022 to 2028. Surge in allergies and infectious diseases and growing awareness among patients and benefits offered by nasal irrigation are the critical factors attributed to the Middle East & Africa nasal irrigation devices market expansion.

Nasal irrigation has a long history from traditional Ayurveda medicines, which are now adopted in Middle East & Africa. There have been several advancements in nasal irrigation devices over the years. From squeeze bottles to neti pots, these devices have evolved. The development of battery-powered and electric nasal irrigation devices, which could consistently flow saline water into the nasal cavity, was ground-breaking. These devices are developed considering the pressure that helps in the efficient removal of allergens and mucus. Recently, a novel nasal irrigation device with an extended nozzle was developed, which is more efficient than conventional devices, such as squeeze bottles. This is expected to drive the Middle East & Africa nasal irrigation devices market during the forecast period.

On the contrary, challenges connected with nasal irrigation devices hurdles the growth of Middle East & Africa nasal irrigation devices market. 

Based on product type, the Middle East & Africa nasal irrigation devices market is categorized into manual nasal irrigators, electric nasal irrigators, and battery powered nasal irrigators. The manual nasal irrigators segment held 46.0% market share in 2022, amassing US$ 10.54 million. It is projected to garner US$ 24.34 million by 2028 to expand at 15.0% CAGR during 2022–2028.

Based on patient type, the Middle East & Africa nasal irrigation devices market is bifurcated into pediatrics and adult. The adult segment held 59.0% market share in 2022, amassing US$ 13.51 million. It is projected to garner US$ 33.09 million by 2028 to expand at 16.1% CAGR during 2022–2028.

Based on application, the Middle East & Africa nasal irrigation devices market is categorized into rhinitis, sinus, bronchiolitis, post-operative respiratory conditions, and others. The sinus segment held 31.7% of the Middle East & Africa nasal irrigation devices market share in 2022, amassing US$ 7.27 million. It is projected to garner US$ 18.00 million by 2028 to expand at 16.3% CAGR during 2022–2028.

Based on end user, the Middle East & Africa nasal irrigation devices market is categorized into hospitals & clinics, home care, and others. The home care segment held 39.6% of the Middle East & Africa nasal irrigation devices market share in 2022, amassing US$ 9.08 million. It is projected to garner US$ 22.47 million by 2028 to expand at 16.3% CAGR during 2022–2028.

Based on country, the Middle East & Africa nasal irrigation devices market has been categorized into the Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa.  Our regional analysis states that China captured 39.5% market share in 2022. It was assessed at US$ 9.05 million in 2022 and is likely to hit US$ 22.33 million by 2028, exhibiting a CAGR of 16.2% during the forecast period.

Key players dominating the Middle East & Africa nasal irrigation devices market are Air Liquide Medical Systems; Neilmed Pharmaceuticals Inc.; Stryker Corp; Medtronic Plc; and Bayer AG among others.

• In May 2022, Medtronic completes acquisition of Intersect ENT.
• In June 2019, Air Liquide reinforces its presence in Middle East & Africa with the acquisition of Medidis in the Netherlands.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com